Statistics for Secondary 12-Month Ocular Outcomes of a Phase 1 Dosing Study of Bevacizumab for Retinopathy of Prematurity
Total visits
| views | |
|---|---|
| Secondary 12-Month Ocular Outcomes of a Phase 1 Dosing Study of Bevacizumab for Retinopathy of Prematurity | 104 |
Total visits per month
| views | |
|---|---|
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
File Visits
| views | |
|---|---|
| Secondary 12-Month Ocular Outcomes of a Phase 1 Dosing Study of Bevacizumab for Retinopathy of Prematurity.pdf | 144 |
| java.util.UUID:f32dc095-d844-4eb5-9266-bad7dca3b85f | 65 |
| java.util.UUID:44ed7cc7-2626-4434-b304-0d5e32227ce7 | 7 |
| java.util.UUID:96b54261-4005-45ae-957d-a53beb22d879 | 3 |
Top country views
| views | |
|---|---|
| United States | 86 |
| China | 2 |
| Vietnam | 2 |
| France | 1 |
| Japan | 1 |
| Malaysia | 1 |
| Sweden | 1 |
Top city views
| views | |
|---|---|
| Wilmington | 44 |
| Fairfield | 10 |
| White Plains | 7 |
| Houston | 4 |
| Ann Arbor | 3 |
| Chicago | 3 |
| Lake Mary | 3 |
| Baltimore | 2 |
| Dong Ket | 2 |
| Asheville | 1 |
| Beijing | 1 |
| Cambridge | 1 |
| Seremban | 1 |
| Stockholm | 1 |
| Westbury | 1 |